These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 23836370)

  • 1. Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study.
    Ceravolo R; Cossu G; Bandettini di Poggio M; Santoro L; Barone P; Zibetti M; Frosini D; Nicoletti V; Manganelli F; Iodice R; Picillo M; Merola A; Lopiano L; Paribello A; Manca D; Melis M; Marchese R; Borelli P; Mereu A; Contu P; Abbruzzese G; Bonuccelli U
    Mov Disord; 2013 Sep; 28(10):1391-7. PubMed ID: 23836370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and features of peripheral neuropathy in Parkinson's disease patients under different therapeutic regimens.
    Mancini F; Comi C; Oggioni GD; Pacchetti C; Calandrella D; Coletti Moja M; Riboldazzi G; Tunesi S; Dal Fante M; Manfredi L; Lacerenza M; Cantello R; Antonini A
    Parkinsonism Relat Disord; 2014 Jan; 20(1):27-31. PubMed ID: 24099722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fiber selectivity of peripheral neuropathy in patients with Parkinson's disease.
    Xiong YT; Liu MH; Gu HY; Li K; Zhang JR; Cheng XY; Jin H; Chen J; Mao CJ; Liu CF
    Acta Neurol Scand; 2022 Jul; 146(1):75-81. PubMed ID: 35466436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia.
    Zoccolella S; dell'Aquila C; Abruzzese G; Antonini A; Bonuccelli U; Canesi M; Cristina S; Marchese R; Pacchetti C; Zagaglia R; Logroscino G; Defazio G; Lamberti P; Livrea P
    Mov Disord; 2009 May; 24(7):1028-33. PubMed ID: 19353704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective assessment of peripheral neuropathy in Duodopa-treated parkinsonian patients.
    Merola A; Zibetti M; Rizzone MG; Troiano M; Artusi CA; Angrisano S; Cocito D; Lopiano L
    Acta Neurol Scand; 2014 Jan; 129(1):e1-5. PubMed ID: 23834498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathy in Parkinson disease: prevalence and determinants.
    Rajabally YA; Martey J
    Neurology; 2011 Nov; 77(22):1947-50. PubMed ID: 22049200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No association between neuropathy and restless legs in Parkinson's disease.
    Rajabally YA; Martey J
    Acta Neurol Scand; 2013 Mar; 127(3):216-20. PubMed ID: 22989006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma homocysteine level and its relationship to clinical profile in Parkinson's disease patients at the Lagos University Teaching Hospital.
    Ojo OO; Oladipo OO; Ojini FI; Sanya EO; Danesi MA; Okubadejo NU
    West Afr J Med; 2011; 30(5):319-24. PubMed ID: 22752818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum methylmalonic acid correlates with neuropathic pain in idiopathic Parkinson's disease.
    Park JS; Park D; Ko PW; Kang K; Lee HW
    Neurol Sci; 2017 Oct; 38(10):1799-1804. PubMed ID: 28726051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral neuropathy in 30 duodopa patients with vitamins B supplementation.
    Rispoli V; Simioni V; Capone JG; Golfrè Andreasi N; Preda F; Sette E; Tugnoli V; Sensi M
    Acta Neurol Scand; 2017 Dec; 136(6):660-667. PubMed ID: 28608472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum homocysteine and physical exercise in patients with Parkinson's disease.
    Nascimento CM; Stella F; Garlipp CR; Santos RF; Gobbi S; Gobbi LT
    Psychogeriatrics; 2011 Jun; 11(2):105-12. PubMed ID: 21707858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levodopa-associated increase of homocysteine levels and sural axonal neurodegeneration.
    Müller T; Renger K; Kuhn W
    Arch Neurol; 2004 May; 61(5):657-60. PubMed ID: 15148140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced plasma homocysteine levels in levodopa/entacapone treated Parkinson patients.
    Valkovic P; Benetin J; Blazícek P; Valkovicová L; Gmitterová K; Kukumberg P
    Parkinsonism Relat Disord; 2005 Jun; 11(4):253-6. PubMed ID: 15878587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperhomocysteinemia due to levodopa treatment as a risk factor for osteoporosis in patients with Parkinson's disease.
    Lee SH; Kim MJ; Kim BJ; Kim SR; Chun S; Kim HK; Ryu JS; Kim GS; Lee MC; Chung SJ; Koh JM
    Calcif Tissue Int; 2010 Feb; 86(2):132-41. PubMed ID: 20049422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine in restless legs syndrome.
    Bachmann CG; Guth N; Helmschmied K; Armstrong VW; Paulus W; Happe S
    Sleep Med; 2008 May; 9(4):388-92. PubMed ID: 17900981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropathy as a potential complication of levodopa use in Parkinson's disease.
    Toth C; Brown MS; Furtado S; Suchowersky O; Zochodne D
    Mov Disord; 2008 Oct; 23(13):1850-9. PubMed ID: 18785232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease.
    Toth C; Breithaupt K; Ge S; Duan Y; Terris JM; Thiessen A; Wiebe S; Zochodne DW; Suchowersky O
    Ann Neurol; 2010 Jul; 68(1):28-36. PubMed ID: 20582991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral Neuropathy in
    Lee JJ; Baik JS
    Yonsei Med J; 2020 Dec; 61(12):1050-1053. PubMed ID: 33251779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma homocysteine levels in patients treated with levodopa: motor and cognitive associations.
    Ozer F; Meral H; Hanoglu L; Aydemir T; Yilsen M; Cetin S; Ozturk O; Seval H; Koldas M
    Neurol Res; 2006 Dec; 28(8):853-8. PubMed ID: 17288745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modest increase in plasma homocysteine follows levodopa initiation in Parkinson's disease.
    O'Suilleabhain PE; Bottiglieri T; Dewey RB; Sharma S; Diaz-Arrastia R
    Mov Disord; 2004 Dec; 19(12):1403-8. PubMed ID: 15390053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.